Mar 30, 2010
FTC’s ‘Pay for Delay’ Case Against Cephalon Moves Forward
The Federal Trade Commission’s crusade against “pay for delay” patent settlements between brand-name and generic drug makers got a boost Monday when a district court judge refused to dismiss a 2008 antitrust suit against Cephalon Inc. The case, now consolidated in U.S.